[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-345704-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-345704-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","bmi-based-metabolic-syndrome-z-score-and-gastrointestinal-cancers-a-cohort-study","BMI-based metabolic syndrome Z-score and gastrointestinal cancers - A cohort study","","Obesity is closely tied to metabolic syndrome and digestive malignancies, yet the true relationship with digestive cancer risk remains disputed. Using the Kailuan cohort, researchers evaluated how the metabolic syndrome severity Z-score relates to digestive system cancers in a Chinese population. A total of 48,205 participants with three consecutive examinations since 2006 were followed for a median of 11.03 years. Cox models showed higher cumulative severity Z-score was associated with increased gastrointestinal cancer risk, especially for esophageal cancer.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/bmi-based-metabolic-syndrome-z-score-and-gastrointestinal-cancers-a-cohort-study/345704/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/bmi-based-metabolic-syndrome-z-score-and-gastrointestinal-cancers-a-cohort-study/345704.png","ImageObject",300,407,{"name":42,"@type":43},"Sage","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What study population and follow-up were used to assess the risk of digestive cancers?","Question",{"text":63,"@type":64},"The study used 48,205 participants from the Kailuan cohort who underwent three consecutive physical examinations since 2006 and were followed for a median of 11.03 years.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was metabolic syndrome severity measured in relation to cancer risk?",{"text":68,"@type":64},"The cumulative metabolic syndrome severity Z-score (cMets-Z) was calculated using fasting blood glucose, total cholesterol, HDL, systolic blood pressure, body mass index, and related parameters.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the main findings regarding the association between cMets-Z and gastrointestinal cancers?",{"text":72,"@type":64},"Adjusted hazard ratios increased across higher cMets-Z groups, indicating a higher risk of gastrointestinal cancers, with the effect more pronounced for esophageal cancer.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},345704,1790168478,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":112,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":118,"preview_page_count":33,"preview_urls":145},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","®  \n Observational Study   \nBMI-based metabolic syndrome Z-score and gastrointestinal cancers  \nA cohort study  \nWanchao Wang, MMa , Kuan Liu, MMa ,b , Yang Zhang, MSc , Jiaxing Li, MMd , Chao Ma, MMe , Shouling Wu, MDf , Siqing Liu, MMa ,*  \n\n| Abstract\u003Cbr>Obesity is not only an important part of metabolic syndrome, but also closely related to the pathogenesis of a variety of malignancies. However, there are differing views on the relationship between obesity and the risk of digestive malignancies. In this context, it is necessary to assess the true cancer risk in people with different obesity states. In the past, some researchers proposed to use the metabolic syndrome severity z score to predict the risk of certain diseases, but since its introduction, there has been a lack of relevant studies in the Chinese population. Based on the Kailuan cohort, the association between metabolic syndrome severity z score and the risk of digestive system malignancy in the Chinese population was explored. In this study, 48,205 participants who had undergone 3 consecutive physical examinations since 2006 were collected. Cumulative metabolic syndrome severity z score (cMets-Z) was calculated using parameters such as fasting blood glucose, total cholesterol, high-density lipoprotein, systolic blood pressure, and body mass index. Participants were categorized into 4 groups based on cMetS-Z (Q1–Q4), and a Cox regression model was used to evaluate the risk of new digestive system malignancies. The mean age of participants was 48.99 ± 11.75 years. Over a median follow-up period of 11.03 years, 749 new cases of digestive cancers were identified, including esophageal, gastric, colorectal, liver, bile duct, and pancreatic cancers. Cox proportional hazards modeling revealed adjusted hazard ratios for gastrointestinal cancers in the Q2 to Q4 groups as 1.19 (0 .96–1.48), 1.36 (1 .08–1.71), and 1.72 (1 .33–2.23) . In site-specific analyses, we observed that this risk was more pronounced in esophageal cancer. Subgroup analyses showed that cMetS-Z was associated with digestive system malignancies, particularly in male participants with metabolic syndrome. Restricted cubic spline regresion results showed that cMets-Z had a linear relationship with the risk of digestive system tumors. We found that cMetS-Z was associated with an increased risk of gastrointestinal cancer. cMetS-Z can be used as a prospective tool to predict the risk of gastrointestinal malignancies in Chinese people. |\n| --- |\n| Abbreviations: BMI = body mass index, cMets-Z = cumulative metabolic syndrome severity z score, DBP = diastolic blood pressure, FBG = fasting blood glucose, GI = gastrointestinal, HDL = high-density lipoprotein, HLP = hyperlipidemia, hsCRP = high-sensitivity C-reactive protein, HTN = hypertension, LDL = low-density lipoprotein, MetS = metabolic syndrome, Mets-Z = metabolic syndrome severity z score, SBP = systolic blood pressure, TG = triglyceride, WC = waist circumference. |\n| Keywords: cMets-z, cohort study, digestive system cancer, obesity, risk factor |\n\n1. Introduction  \nGastrointestinal (GI) cancers include malignancies of the esophagus, stomach, small bowel, colorectum, liver, pancreas, extrahepatic bile duct, and gallbladder. According to Global Cancer  \nStatistics 2023, 3 of the 5 leading causes of cancer mortality worldwide are digestive system cancers – colorectal (9%), pancreatic (8%), and liver (6%) . [1] In China, liver cancer ranks as the 2nd leading cause of cancer death, followed by gastric,  \nWW and KL contributed to this article equally.  \nSL and SW contributed to this article equally.  \nThe authors have no funding and conflicts of interest to disclose. The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.  \nThe project was approved by the Ethics Committee of Kailuan Hospital, batch number: 200605, registration number: ChiCTR-TNC-11001489, and all subjects signed the","cbCainW1LnUZrSkY","https://ap.wps.com/l/cbCainW1LnUZrSkY","pdf",1663686,"English","# Abstract\n# Introduction","[{\"question\":\"What study population and follow-up were used to assess the risk of digestive cancers?\",\"answer\":\"The study used 48,205 participants from the Kailuan cohort who underwent three consecutive physical examinations since 2006 and were followed for a median of 11.03 years.\"},{\"question\":\"How was metabolic syndrome severity measured in relation to cancer risk?\",\"answer\":\"The cumulative metabolic syndrome severity Z-score (cMets-Z) was calculated using fasting blood glucose, total cholesterol, HDL, systolic blood pressure, body mass index, and related parameters.\"},{\"question\":\"What were the main findings regarding the association between cMets-Z and gastrointestinal cancers?\",\"answer\":\"Adjusted hazard ratios increased across higher cMets-Z groups, indicating a higher risk of gastrointestinal cancers, with the effect more pronounced for esophageal cancer.\"}]","BMI-based metabolic syndrome Z-score and gastrointestinal cancers - A cohort study | PDF",1790058658,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/88579bd5f14fee39329e352930b5c80f.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3db222fe012156b1f373d0af70a9c78b.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d23e1a7bc369622ec12cef41807089ed.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f59d30f96f70f4292d550184a2c84022.webp",980,1306]